Transplantation-related thrombotic microangiopathy triggered by preemptive therapy for hepatitis C virus infection.
Shintaro
S
Yamazaki
Tadatoshi
T
Takayama
Kazuto
K
Inoue
Tokio
T
Higaki
Masatoshi
M
Makuuchi
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D001921:Brain / Q000187:drug effects / Q000473:pathology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000633:toxicity; D016031:Liver Transplantation / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced*; D016559:Tacrolimus / Q000633:toxicity
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D016559:Tacrolimus